Economic Evaluation of Denosumab for Treatment of Postmenopausal Osteoporosis: A Systematic Review
Background: We aimed to review the systematic economic evaluation of denosumab versus than alternative drugs and oral bisphosphonates of postmenopausal osteoporosis in women and help health system policy makers for prioritizing and optimally allocate limited health resources. Methods: We examine...
Main Authors: | Shahin Nargesi, Saeed Husseini Barghazan, Nadia Sani'ee, Asma Rashki Kemmak |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2022-07-01
|
Series: | Iranian Journal of Public Health |
Subjects: | |
Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/24562 |
Similar Items
-
Efficacy of the Combination of Teriparatide and Denosumab in the Treatment of Postmenopausal Osteoporosis: A Meta-Analysis
by: Yang Sun, et al.
Published: (2022-05-01) -
Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study
by: Nihal Tezel, et al.
Published: (2021-12-01) -
Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?
by: Anna Wawrzyniak, et al.
Published: (2023-01-01) -
Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
by: Yong-Ki Min
Published: (2015-03-01) -
The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
by: Yilin Zhu, et al.
Published: (2020-05-01)